SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 1 filers reported holding SERES THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,795 | -38.6% | 4,956 | +23.5% | 0.00% | -100.0% |
| Q2 2023 | $19,222 | +73830.8% | 4,013 | -11.1% | 0.00% | 0.0% |
| Q1 2023 | $26 | -66.7% | 4,512 | -67.7% | 0.00% | -66.7% |
| Q4 2022 | $78 | -99.8% | 13,956 | +76.8% | 0.00% | +200.0% |
| Q3 2022 | $50,000 | +100.0% | 7,892 | +7.1% | 0.00% | 0.0% |
| Q2 2022 | $25,000 | -79.3% | 7,372 | -56.7% | 0.00% | 0.0% |
| Q1 2022 | $121,000 | -54.2% | 17,040 | -46.3% | 0.00% | -80.0% |
| Q4 2021 | $264,000 | +7.8% | 31,742 | -9.8% | 0.01% | -16.7% |
| Q3 2021 | $245,000 | +4.7% | 35,176 | +259.7% | 0.01% | 0.0% |
| Q2 2021 | $234,000 | -82.0% | 9,779 | -84.5% | 0.01% | -72.7% |
| Q1 2021 | $1,302,000 | +2225.0% | 63,233 | +2684.4% | 0.02% | +1000.0% |
| Q4 2020 | $56,000 | -84.9% | 2,271 | -82.6% | 0.00% | -50.0% |
| Q3 2020 | $370,000 | +704.3% | 13,056 | +34.5% | 0.00% | +100.0% |
| Q2 2020 | $46,000 | +9.5% | 9,708 | -21.1% | 0.00% | -33.3% |
| Q4 2019 | $42,000 | +50.0% | 12,311 | +41.9% | 0.00% | +50.0% |
| Q2 2019 | $28,000 | +1300.0% | 8,678 | +3656.7% | 0.00% | – |
| Q1 2019 | $2,000 | -97.0% | 231 | -98.4% | 0.00% | -100.0% |
| Q4 2018 | $67,000 | +55.8% | 14,753 | +160.0% | 0.01% | +66.7% |
| Q3 2018 | $43,000 | +437.5% | 5,674 | +487.4% | 0.00% | – |
| Q2 2018 | $8,000 | -84.9% | 966 | -86.5% | 0.00% | -100.0% |
| Q1 2018 | $53,000 | +152.4% | 7,171 | +239.5% | 0.01% | +66.7% |
| Q4 2017 | $21,000 | -76.7% | 2,112 | -62.5% | 0.00% | -57.1% |
| Q3 2017 | $90,000 | +87.5% | 5,631 | +31.5% | 0.01% | +40.0% |
| Q2 2017 | $48,000 | +4700.0% | 4,283 | +4315.5% | 0.01% | – |
| Q1 2017 | $1,000 | -95.8% | 97 | -95.9% | 0.00% | -100.0% |
| Q4 2016 | $24,000 | -29.4% | 2,387 | -12.5% | 0.00% | 0.0% |
| Q3 2016 | $34,000 | +30.8% | 2,729 | +177.1% | 0.00% | -25.0% |
| Q1 2016 | $26,000 | +550.0% | 985 | +820.6% | 0.00% | +300.0% |
| Q4 2015 | $4,000 | +33.3% | 107 | +24.4% | 0.00% | – |
| Q3 2015 | $3,000 | – | 86 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 12,682,876 | $125,560,000 | 40.85% |
| ARK Investment Management | 492,064 | $4,871,000 | 1.77% |
| Artal Group S.A. | 700,000 | $6,930,000 | 0.15% |
| Portolan Capital Management | 111,054 | $1,099,000 | 0.15% |
| Rock Springs Capital Management LP | 220,000 | $2,178,000 | 0.15% |
| CQS Cayman LP | 162,000 | $1,604,000 | 0.13% |
| Opus Point Partners Management, LLC | 14,000 | $139,000 | 0.11% |
| HAMILTON LANE ADVISORS LLC | 14,883 | $147,000 | 0.10% |
| Geduld E E | 15,000 | $149,000 | 0.08% |
| Virtus ETF Advisers LLC | 28,148 | $279,000 | 0.08% |